Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy.

Metz, Raphaël; Rauscher, Aurore; Vaugier, Loïg; Supiot, Stéphane; Drouet, Franck; Campion, Loic; Rousseau, Caroline

Metz, Raphaël; Rauscher, Aurore; Vaugier, Loïg; Supiot, Stéphane; Drouet, Franck; Campion, Loic; Rousseau, Caroline.

Afiliação

Metz R; Nuclear Medicine Department, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, F-44800 St-Herblain, France.
Rauscher A; Nuclear Medicine Department, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, F-44800 St-Herblain, France.
Vaugier L; Radiation Oncology Department, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, F-44800 St-Herblain, France.
Supiot S; Radiation Oncology Department, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, F-44800 St-Herblain, France.
Drouet F; Laboratoire US2B, Unité en Sciences Biologiques et Biotechnologies, UMR CNRS 6286, UFR SCIENCES ET TECHNIQUES, 2, Rue de la Houssinière, F-44322 Nantes, France.
Campion L; Radiation Oncology Department, Clinique Mutualiste de l'Estuaire, F-44600 Saint-Nazaire, France.
Rousseau C; Biostatistics Department, Institut de Cancérologie de l'Ouest, Boulevard J. Monod, F-44800 St-Herblain, France.

Cancers (Basel) ; 15(6)2023 Mar 22.

Article em En | MEDLINE | ID: mdl-36980784

Palavras-chave

PET/CT; [18F]F-choline; [68Ga]Ga-PSMA; external radiotherapy; oligorecurrent; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google